NCT01445119View on ClinicalTrials.gov

A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Recurrent Gliomas
Interventions
DRUG

Enzastaurin (LY317615)

DRUG

Carboplatin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eli Lilly and Company

INDUSTRY

NCT01445119 - A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas | Biotech Hunter | Biotech Hunter